Varex Imaging Corp (NASDAQ: VREX) insider details RSU vesting and 26,041-unit grant

Rhea-AI Filing Summary

Varex Imaging Corp executive Mark S. Jonaitis, SVP and GM, X-Ray Sources, reported equity compensation activity dated December 10, 2025. Two restricted stock unit awards converted into a total of 12,599 shares of common stock, increasing his direct holdings before tax withholding. To satisfy associated tax obligations, 5,526 shares were withheld at a price of $11.70 per share, leaving him with 77,341 shares of common stock owned directly.

He also received a new grant of 26,041 restricted stock units, each convertible into one share of common stock. This grant is scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029, while earlier RSU grants include vesting through December 10, 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jonaitis Mark S.

(Last) (First) (Middle)

C/O VAREX IMAGING CORP

1678 S. PIONEER ROAD

(Street)

SALT LAKE CITY UT 84104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and GM, X-Ray Sources

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		M		4,664	A	(1)	74,932(2)	D
Common Stock	12/10/2025		M		7,935	A	(1)	82,867	D
Common Stock	12/10/2025		F		5,526(3)	D	$11.7	77,341	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	12/10/2025		M			4,664	(4)	(4)	Common Stock	4,664	$0	0	D
Restricted Stock Units	(1)	12/10/2025		M			7,935	(5)	(5)	Common Stock	7,935	$0	7,936	D
Restricted Stock Units	(1)	12/10/2025		A		26,041		(6)	(6)	Common Stock	26,041	$0	26,041	D

Explanation of Responses:

1. Each Restricted Stock Unit converts into common stock on a one-for-one basis.

2. Includes 2,100 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person.

3. These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

4. These Restricted Stock Units granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date.

5. These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date.

6. These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.

Remarks:

	/s/ Matthew A. Martinez, attorney-in-fact for Mark S. Jonaitis	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock activity did Varex Imaging (VREX) report on December 10, 2025?

The filing shows that Mark S. Jonaitis, SVP and GM, X-Ray Sources, had restricted stock units convert into common shares and also received a new restricted stock unit grant on December 10, 2025.

How many Varex Imaging (VREX) shares did Mark S. Jonaitis receive from RSU vesting?

Two restricted stock unit awards converted into 4,664 and 7,935 shares of common stock, for a total of 12,599 shares delivered in connection with the vesting.

Why were 5,526 Varex Imaging (VREX) shares disposed of at $11.70?

The filing states that 5,526 shares were withheld at a price of $11.70 per share to satisfy a tax withholding obligation arising from the vesting of the restricted stock units.

How many Varex Imaging (VREX) shares does Mark S. Jonaitis own after these transactions?

Following the reported transactions, Mark S. Jonaitis beneficially owns 77,341 shares of Varex Imaging common stock directly.

What new restricted stock units did Mark S. Jonaitis receive from Varex Imaging (VREX)?

He received a new grant of 26,041 restricted stock units, each convertible into one share of common stock at no cash exercise price.

What are the vesting schedules for the Varex Imaging (VREX) restricted stock units?

RSUs granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. RSUs granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. RSUs granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029.

What is Mark S. Jonaitis’s role at Varex Imaging (VREX)?

He is an officer of Varex Imaging, serving as SVP and GM, X-Ray Sources, and files as a reporting person for his equity holdings.